Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Dose Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older

Go back to Resources

Dose Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Clinical Trials Referral Resource. Current Phase III Breast Cancer Clinical Trials

Go back to Resources

Clinical Trials Referral Resource. Current Phase III Breast Cancer Clinical Trials

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Go back to Resources

Clinical Trials Referral Resource. Current Clinical Trials in the Treatment of Colorectal Cancer

Go back to Resources

Clinical Trials Referral Resource. Current Clinical Trials in the Treatment of Colorectal Cancer

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Go back to Resources

Challenges in the Design and Conduct of a Randomized Study of Two Interventions for Liquid Aspiration

Go back to Resources

Challenges in the Design and Conduct of a Randomized Study of Two Interventions for Liquid Aspiration

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Centrum Use and Progression of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS): A Propensity Score Approach. AREDS Report No. 21

Go back to Resources

Centrum Use and Progression of Age-Related Cataract in the Age-Related Eye Disease Study (AREDS): A Propensity Score Approach. AREDS Report No. 21

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Ciliary Neurotrophic Factor (CNTF) For Human Retinal Neurodegeneration: Phase I Trial of CNTF Delivered by Encapsulated Cell Intraocular Implants

Go back to Resources

Ciliary Neurotrophic Factor (CNTF) For Human Retinal Neurodegeneration: Phase I Trial of CNTF Delivered by Encapsulated Cell Intraocular Implants

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience

Go back to Resources

Challenges of Use and Compliance With Effective Contraceptives Among Female Participants in Preventive HIV Vaccine Trials: The Kenyan Experience

Authors:

Secondary:

Location:

URL:

Go back to Resources

Cataract Risk Factors in a Subgroup of Patients Age 80 and Older From the Age-Related Eye Disease Study

Go back to Resources

Cataract Risk Factors in a Subgroup of Patients Age 80 and Older From the Age-Related Eye Disease Study

Authors:

Location:

Go back to Resources

Cataract Phenotyping Using Serial Examinations in the Age-Related Eye Disease Study (AREDS)

Go back to Resources

Cataract Phenotyping Using Serial Examinations in the Age-Related Eye Disease Study (AREDS)

Authors:

Location:

Go back to Resources

Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions

Go back to Resources

Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 158
  • Page 159
  • Page 160
  • Page 161
  • Current page 162
  • Page 163
  • Page 164
  • Page 165
  • Page 166
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification

Cookie Policy

Our site uses cookies for analytics and to improve our site and services. You can manage these cookies via your browser settings at any time. By continuing to use our site, you agree to our use of cookies. For more information, including how to change your settings, see our Cookie Policy.